Solid lipid nanoparticles for enhanced oral absorption: A review
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Recent trends in nanoparticles-based oral therapy have led to a proliferation of studies to enhance solubility, permeability and chemical stability of many drugs. One of the significant current discussions is achieving high bioavailability of drugs poorly absorbed with an impairing coincidence of oral degradation. Solid lipid nanoparticles (SLNs), absorbed and trafficked via transcellular and paracellular pathways, are one of the utmost innovative promising nanocarriers to overwhelm drawbacks of the poorly absorbed drugs. The central topic of this review is focusing on providing brief updates on SLNs for improving drug oral absorption with their evolutions in curing numerous ailments. In order to create a new paradigm of therapeutic formulations, we also highlight the transversal mechanisms of SLNs across the gastrointestinal hurdles and a series of novel researches regarding in vitro protocols to uncover the investigations of the transmembrane absorption and transport kinetics of SLNs. The current challenges and future perspectives of SLNs for oral drug delivery are refined and forecasted. Several questions remain unanswered and it is recommended to pay a close attention to the most sophisticated in vivo-like culture practices which open new avenues to thoroughly elucidate how SLNs interact with intestinal mucosa at cellular and molecular levels. Additionally, further studies are needed to concentrate on the factors influencing the absorption efficiency, proportion of SLNs in gastrointestinal tract as well as their correlation with their loaded drug bioavailability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation
Kim, H. J., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40126j · Cited by 750
Is the oral route possible for peptide and protein drug delivery?
Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.005 · Cited by 515
Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442
Harush-Frenkel, O., Rozentur, E., Benita, S., & Altschuler, Y. (2008) · Biomacromolecules · doi:10.1021/bm700535p · Cited by 405
Tight junction modulation and its relationship to drug delivery
SALAMA, N., EDDINGTON, N., & FASANO, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.003 · Cited by 357
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Pandey, R., Sharma, S., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.08.009 · Cited by 271
Expression of specific markers and particle transport in a new human intestinal M-cell model
Gullberg, E., Leonard, M., Karlsson, J., Hopkins, A. M., Brayden, D., Baird, A. W., & Artursson, P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4038 · Cited by 270
Chitcholtan, K., Asselin, E., Parent, S., Sykes, P. H., & Evans, J. J. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.09.012 · Cited by 173
Cited by
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Scioli Montoto, S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 652
Thi, T. T. H., Suys, E. J. A., Lee, J. S., Nguyen, D. H., Park, K. D., & Truong, N. P. (2021) · Vaccines · doi:10.3390/vaccines9040359 · Cited by 525
Application of Advanced Emulsion Technology in the Food Industry: A Review and Critical Evaluation
Tan, C., & McClements, D. J. (2021) · Foods · doi:10.3390/foods10040812 · Cited by 321
Oral lipid nanomedicines: Current status and future perspectives in cancer treatment
El Moukhtari, S. H., Rodríguez-Nogales, C., & Blanco-Prieto, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.004 · Cited by 70
Mu, X., Mu, C., Wang, M., Meng, C., Liu, H., & Lu, H. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s552644 · Cited by 16
Metadata
- Authors
- Salah, E., Abouelfetouh, M. M., Pan, Y., Chen, D., & Xie, S.
- Venue
- Colloids and Surfaces B: Biointerfaces
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 196
- Pages
- 111305
- ISSN
- 0927-7765 (ISSN-L)
- OpenAlex
- W3047510030
- Cited by
- 152
- References
- 12
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Solid lipid nanoparticles for enhanced oral absorption: A review. https://app.cochat.ai/papers/10.1016/j.colsurfb.2020.111305
- The paper
- Salah, E., Abouelfetouh, M. M., Pan, Y., Chen, D., & Xie, S. (2020). Solid lipid nanoparticles for enhanced oral absorption: A review. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2020.111305
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.